19 Mar 2015

Everolimus-eluting stents or bypass surgery for multivessel coronary disease

test results and registry studies have shown the long-term mortality is lower after coronary artery bypass surgery (CABG) after percutaneous coronary intervention (PCI) in patients with multivessel disease. These previous analyzes did not assess PCI with drug-eluting stents second generation. In a registry study of contemporary clinical practice, the risk of death associated with PCI with everolimus-eluting stents was similar to that of the CRC. PCI was associated with an increased risk of myocardial infarction (in patients with incomplete revascularization) and repeat revascularization, but a lower risk of stroke.

No comments:

Post a Comment